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toF-sIMs mediated analysis of 
human lung tissue reveals increased 
iron deposition in CopD (GoLD IV) 
patients
Neda Najafinobar1, shalini Venkatesan2, Lena von sydow1, Magnus Klarqvist3, 
Henric olsson2, Xiao-Hong Zhou2, suzanne M. Cloonan4 & per Malmberg  5
Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease that is currently the third 
leading cause of death worldwide. Recent reports have indicated that dysfunctional iron handling in 
the lungs of COPD patients may be one contributing factor. However, a number of these studies have 
been limited to the qualitative assessment of iron levels through histochemical staining or to the 
expression levels of iron-carrier proteins in cells or bronchoalveolar lavage fluid. In this study, we have 
used time of flight secondary ion mass spectrometry (ToF-SIMS) to visualize and relatively quantify 
iron accumulation in lung tissue sections of healthy donors versus severe CopD patients. An IoNtoF 
5 instrument was used to perform the analysis, and further multivariate analysis was used to analyze 
the data. An orthogonal partial least squares discriminant analysis (opLs-DA) score plot revealed good 
separation between the two groups. This separation was primarily attributed to differences in iron 
content, as well as differences in other chemical signals possibly associated with lipid species. Further, 
relative quantitative analysis revealed twelve times higher iron levels in lung tissue sections of CopD 
patients when compared to healthy donors. In addition, iron accumulation observed within the cells 
was heterogeneously distributed, indicating cellular compartmentalization.
Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease encompassing airway inflammation 
(chronic bronchitis), destruction of lung tissue (emphysema) and remodeling of the small airways1. With increas-
ing global burden, COPD is currently the third leading cause of death worldwide2,3. Cigarette smoke exposure 
remains one of the main etiological factors for COPD3. Tobacco smoke contains 440–1150 µg/g of iron, of which 
0.06% is transferred to mainstream cigarette smoke. Lung exposure to iron increases upon regular cigarette smok-
ing2, potentially as a result of direct supply of iron through cigarette smoke, or as a result of complexation of host 
iron by oxygen donor ligands found on cigarette smoke particulate matter. Abnormally increased iron deposition 
has been reported in the lungs of both current and former smokers3,4. Furthermore, levels of non-heme iron 
and of iron-binding proteins including ferritin, lipocalin-2 and lactoferrin, are increased in lung tissue, sputum, 
BALF, and cells of COPD patients, relative to non-smokers4–15. Although cigarette smoking is the major cause of 
COPD, occupational exposures, including those to dust, fumes and diesel exhaust, have emerged as important 
additional risk factors for COPD, especially in nonsmokers16. Iron has also been shown to accumulate in lung 
tissue of people exposed to particulate air pollutions17, suggesting this may be another source of iron linked to an 
increased risk of developing COPD.
Although iron is an essential trace element required for many vital biological processes viz oxygen transport 
and energy production, increased free iron could be detrimental due to its potential to generate free radicals18. 
In addition to environmental risk factors such as cigarette smoke, genetic factors have also been reported to 
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influence COPD susceptibility1. Genome wide association studies have identified iron responsive element binding 
protein 2 (IREB2) as an important candidate for a COPD susceptibility gene, suggesting a functional disease link 
between abnormal iron metabolism and COPD2,3. IREB2 is a gene on human chromosome 15, coding for iron 
regulatory protein 2 (IRP2), which plays a vital role in maintaining cellular iron homeostasis2,18.
According to the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria, COPD patients are 
classified into GOLD stage I (Mild), Stage II (Moderate), Stage III (Severe) and Stage IV (Very severe) based on 
the severity of airflow limitation19. In this study, we have employed time of flight secondary ion mass spectrom-
etry (ToF-SIMS) to visualize and relatively quantify iron accumulation in human lung tissue sections of COPD 
(GOLD IV) patients versus (vs.) healthy donors. Previous studies have employed manual methods for iron quan-
tification in diseased vs. healthy human or mouse lung tissue sections1,7, which inevitably introduces risks of 
biased data interpretation and variability between analyses. ToF-SIMS is a versatile technique that has been used 
in different areas of research, including analysis of metals20, polymers21 and complex biological samples. Over the 
recent years this technique has been introduced for biomedical studies on human tissue samples such as liver22, 
kidney23, skeletal muscle24 and various forms of cancer such as prostate cancer25 and breast cancer26.
In this technique, a microfocused beam is impinged on discrete points of a sample surface, generating sec-
ondary ions that are analyzed to generate a mass spectrum at each pixel point from the sample. When it comes 
to chemical analysis of biological samples, ToF-SIMS is a powerful technique in comparison to other single 
methods, as this technique in parallel can provide identification and localization of substances at high spatial 
resolution (<400 nm) without the need for labelling27,28 and matrix application29. However, with imaging mass 
spectrometry it is still challenging to detect a wide range of ion species with sufficient spatial resolution. To over-
come this limitation, the delayed extraction mode has been developed as an alternative method. In this mode, the 
extracted secondary ions from the sample surface are collected with a certain delay after the arrival of primary 
ions30, which makes it possible to record secondary ion images of ion species with very high spatial resolution and 
a mass resolution of several thousands in a single run.
In the present study, we successfully demonstrate that ToF-SIMS can be employed for visualization and relative 
quantification of iron in human lung tissue sections from both healthy and diseased donors (COPD (GOLD IV)). 
Further, upon application of the delayed extraction mode where spatial resolution down to 400 nm is attainable, 
we can show that the intracellular iron distribution within cells tentatively identified as macrophages, emerging as 
the major cell type responsible for iron accumulation in lung tissue7, is heterogeneous. Thus, ToF-SIMS appears as 
a powerful tool to image and relatively quantify lung tissue iron overload, allowing clear differentiation between 
healthy vs. COPD donors based on their lung tissue iron content. In addition, the technique can distinguish other 
chemical differences such as alterations in lung tissue lipid composition between the two groups.
Results
toF-sIMs imaging reveals a stronger iron signal in CopD (GoLD IV) patients’ lung tissue vs. 
healthy donors. In the present study, we employed ToF-SIMS imaging to map the distribution of iron within 
the complex anatomy of human lung tissue obtained from healthy donors and very severe COPD patients (GOLD 
IV). H&E staining was performed on healthy donors (Fig. 1a) and COPD patients (Fig. 1d) lung tissue sections 
to reveal the cellular distribution (pink (cytoplasm) and purple (nucleus) staining) pattern of the tissue sections. 
Perls’ Prussian (iron) staining performed on the consecutive tissue sections revealed increased iron (blue) stain-
ing in COPD (GOLD IV) patient’s lung tissue (Fig. 1e) vs. healthy donors (Fig. 1b). ToF-SIMS macro stage scan 
images of lung tissue sections analyzed in positive ion mode with Bi3++ primary ions using the high current 
bunched mode were used to visualize the total iron signal (red, m/z 55.9) showing the signal in contrast to pro-
tein fragments (C4H8N+, green, m/z 70.1) in tissue from a healthy donor (Fig. 1c) and a COPD patient (Fig. 1f), 
respectively. The ion images for iron only for both lung tissue sections are shown in Supplementary Fig. S1. The 
full scan ToF-SIMS image of a representative healthy donor’s lung tissue showed only a very weak signal for iron 
(Figs 1c, S1a), whereas the ion signal for iron in lung tissue from a very severe COPD (GOLD IV) patient was 
significantly stronger (Figs 1f, S1b).
Next, iron ion imaging of a COPD (GOLD IV) patient’s lung tissue was compared to standard histochemical 
iron (Perls’ Prussian blue) staining performed on a consecutive lung tissue section. Correlations regarding lung 
tissue regions of iron overloading was observed between the two methods (Fig. 1e,f), however the ToF-SIMS data 
showed several areas with apparent higher iron signals not detectable with Perls’ Prussian blue. In line with the 
poor iron ion signal in Fig. 1c, no evident iron staining was observed in a healthy donor’s lung tissue section as 
seen in Fig. 1b. This validates ToF-SIMS as a powerful technique to localize, map, and visualize the distribution of 
iron in human lung tissue at a high spatial resolution.
It is worth noting though, that for both conventional histochemical iron staining and ToF-SIMS analysis, the 
paraffin fixed lung tissue sections were de-paraffinized using xylene. Since xylene is an aggressive chemical, the 
risk for iron delocalization and leaching needs to be considered. Still, the good correlation between iron staining 
and ToF-SIMS imaging performed on consecutive serial sections indicates that such delocalization is limited. 
Another potential issue is that since the sampling area is relatively big (approximately 15*22 mm), charging and 
topographic effects can be present. Normalisation of the iron signal to the total ion signal did however, not sig-
nificantly alter the ion image for iron. Also, the quality of the obtained spectra based on achieved mass resolution 
and lack of peak tailing (Supplementary Fig. S2), indicates that such problems are less pronounced.
Relative quantification of iron using ToF-SIMS reveals significantly increased iron in COPD 
(GoLD IV) patients’ lung tissue. Studies so far1,7 have mostly relied on manual quantification of iron 
positive cells by histochemical staining (Perls’ Prussian or Perls’-DAB) of lung tissue sections. In this study, we 
used ToF-SIMS for relative quantification of iron in lung tissue sections of healthy donors vs. COPD (GOLD IV) 
patients. For this purpose, three sections from three different donors in each group were chosen, five areas per 
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section were randomly selected for iron imaging, and the ion signal for iron was analyzed and averaged. The rel-
ative quantification revealed approximately twelve times higher levels of iron in COPD (GOLD IV) patients’ lung 
tissue sections compared to that of healthy donors (Fig. 1g,h). These findings are in agreement with a previous 
study, which showed that cigarette smoking increases iron deposition systematically in alveolar macrophages 
from human subjects with COPD, and that the percentage of iron positive macrophages were increased with 
COPD severity7.
Heterogeneous iron distribution at the cellular levels. In continuation to the observation of a strong 
iron ion signal from the COPD (GOLD IV) patients´ lung tissue, we decided to investigate whether the pattern 
Figure 1. ToF-SIMS imaging reveals stronger iron ion signal in COPD (GOLD IV) patients’ lung tissue vs. 
healthy donors. The top panel shows representative images of (a) H&E staining (b) Perls’ Prussian blue (iron) 
staining, and (c) ToF-SIMS overlay image for iron (red, m/z 55.9) and protein fragments (C4H8N+, green, m/z 
70.1) in the lung tissue section of a healthy donor across an analysis area of approximately 16 mm x 20 mm. The 
middle panel (d,e,f) shows the same order of corresponding representative images for a COPD (GOLD IV) 
patient’s lung tissue section; across an analysis area of approximately 15 mm x 22 mm. Scale bars are 4 mm for 
all images. The lower panel (g and h) shows ToF-SIMS mediated relative quantification revealing significantly 
increased iron in COPD (GOLD IV) patients’ lung tissue. (g) Normalized intensity for positive species at m/z 
55.9 (Fe+), for healthy donors and COPD (GOLD IV) patients’ lung tissue. (h) Bar chart showing averaged 
value of iron intensity in healthy donors and COPD (GOLD IV) patients’ lung tissue. The error bars show 95% 
confidence level for each peak in 3 tissue sections per group with 5 random areas per tissue. ***p<0.001, using 
student’s t-test.
4Scientific RepoRts |         (2019) 9:10060  | https://doi.org/10.1038/s41598-019-46471-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
of iron distribution could be assessed down to the cellular or the subcellular level. To achieve this, we used the 
ToF-SIMS delayed extraction mode, allowing lateral resolution down to 400 nm while maintaining a high mass 
resolution. Applying this technique is an efficient way to overcome the issue of compromising between a high 
mass resolution and a sub-µm lateral resolution in conventional ToF-SIMS.
The heterogeneous nature of iron distribution was revealed by overlaying microscopic total ion and iron signal 
images (Fig. 2) of COPD (GOLD IV) patient’s lung tissue sections. The iron enriched cell type was tentatively 
identified as macrophages based on morphology and previously reported data7 and by analyzing consecutive sec-
tions with Perls’ Prussian blue/ nuclear fast red as seen in Fig. 2g. The punctuate subcellular distribution of iron is 
in line with the recent observation that cigarette smoke can induce iron loading in mitochondria1. Mitochondria 
are the main consumers of intracellular iron, and iron regulation by mitochondria may play a vital role in many 
cellular processes1. Similarly, lysosomal iron turnover is also an important component of intracellular iron regu-
lation31 and the contribution of lysosomal iron to these subcellular regions should also be considered. The exact 
subcellular localization of iron inside these macrophages remains to be determined and is currently the subject 
of further investigation.
Following the identification of heterogeneous distribution of iron within the iron positive cells, we performed 
depth profiling on these cells to confirm that the measured iron signal was from intracellular deposits. In this 
mode, the ion intensity in the z-depth, as sputter time (s), of the tissue section can be monitored. The results 
clearly demonstrated that when entering the cells, the signal from iron increased whereas the signal from plasma 
membrane lipids including phosphatidylethanolamine (PE) and phosphatidylcholine (PC) decreased (Fig. 3), 
indicating that the imaged iron signal emanated only from intracellular iron.
Data analysis by PCA and OPLS-DA: OPLS-DA shows a much-improved separation between 
healthy donors and CopD (GoLD IV) compared to pCA. Next, multivariate data analysis was per-
formed to explore whether the lung tissue ToF-SIMS spectra could differentiate and distinguish healthy control 
subjects from COPD patients based on the chemical composition of the tissue.
Principle component analysis (PCA) was carried out on the collected and normalized spectra obtained from 
ToF-SIMS analysis of three different lung tissue samples from each group (healthy donors and COPD (GOLD 
IV)) with five regions for analysis randomly chosen on each sample. In the PCA analysis, the two groups could be 
discerned using the first (PC1: t[1]) vs. the third (PC2: t[3]) principal component (Fig. 4). However, the groups 
weren’t very well separated as the data was influenced by variations within the groups, resulting in scattered data 
points. This was an anticipated variation given that the data was collected from fifteen different scanning regions 
from only three different human samples in each group, which is a low n-number considering the inherent bio-
logical variation between donors and samples.
To improve the separation between the groups, we performed OPLS-DA, a variant of OPLS, focusing specially 
on class separation32. With the same dataset, OPLS-DA analysis revealed an excellent separation between healthy 
donors and COPD (GOLD IV) patients (Fig. 5a). Clearly, the differences between the samples are substantial, 
allowing them to be chemically differentiated into two distinct groups. Although, the samples for COPD group 
are from the same stage (GOLD IV) of disease, it is evident that there are still variations remaining among the 
individuals and within (heterogeneous iron distribution in the lung) giving rise to sample variation.
The loading plot corresponding to the OPLS-DA score plot revealed that iron was one of the most promi-
nent biological masses amongst the highest loading peaks (m/z 55.9) and thus a major driver of the separation 
between the two groups (Fig. 5b). Apart from iron, the peaks with masses of m/z 104, 124.9, 184.1, 240.2, 369.3 
and 394.3 were differentially expressed (over- or under expressed) in the COPD (GOLD IV) samples. These peaks 
are likely to be emanating from different lipids, as it has been previously reported that more than 210 lipids were 
differentially expressed in COPD, including a large portion of sphingolipids that were significantly upregulated 
in smokers with COPD33–35. The lung lipidome and lipid signaling have been implicated in regulating many of 
the biological processes associated with COPD. Several inflammatory cytokines upregulated in COPD have the 
potential to modulate the activity of lipid-modifying enzymes such as phospholipases, sphingomyelinases and 
sphingosine kinases, which might consequently result in an altered lipid composition that could affect cellular 
integrity. For instance, it has been shown that dysregulation of the sphingolipid metabolism may be an impor-
tant driver of progressive alveolar destruction and remodeling in COPD35,36. Thus, analysis of the COPD lung 
lipidome may provide novel approaches to biomarker development and identification of potential therapeutic 
targets33. However, this is not in the scope of this paper and further investigation is required to better understand 
the effect of COPD on lipid expression.
Discussion
ToF-SIMS is a novel analytical technique gaining increasing importance in life sciences due to its relatively high 
spatial resolution and sensitivity combined with its scope for deep chemical profiling analysis. Thus, mass spec-
trometry imaging provides an excellent opportunity to obtain an unprecedented amount of information on the 
distribution of elements and molecules in biological samples37. In the field of pulmonary biology, the ToF-SIMS 
technique has recently been applied to detect the exact localization of inhaled nanoparticles (viz zirconium diox-
ide (ZrO2)38 and silicon dioxide (SiO2)39) in rat lung tissue sections and in aerosolization research to study the 
migration of excipients onto the surface of inhaled drugs40–42. ToF-SIMS has also been employed in lipidomics 
profiling of lung tissue from Pseudomonas aeruginosa infected Cystic Fibrosis Transmembrane Conductance 
Regulator deficient (CFTR−/−) mice. This study reported a significant increase in cholesteryl sulfate (m/z 465.4) 
in lung epithelium from CFTR−/− mice in response to bacterial infection43. ToF-SIMS has also been routinely 
used in studying the lateral organization of lipids and proteins in pulmonary surfactant systems44,45.
Our study has several important strengths. To the best of our knowledge, we are the first to successfully use 
ToF-SIMS to image iron in human lung tissue sections at a spatial resolution of 400 nm and to perform relative 
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iron quantification. This application of ToF-SIMS is highly valuable as it is more precise in quantification and 
less error prone compared to conventional histochemical methods. For example, unlike common histochem-
ical methods, ToF-SIMS detection of iron is not altered by anthracotic material (accumulation of carbon in 
the lungs due to repeated exposure to particles)46, nor dependent on histopathologic scoring, which is at best 
semi-quantitative. Relative quantification of iron load by ToF-SIMS revealed approximately twelve times higher 
levels of iron in lung tissue sections from severe COPD patients as compared to healthy control donors. This 
agrees with a previous qualitative assessment showing increased iron deposition in very severe COPD patients’ 
lung tissue using the Perls’-DAB histochemical iron staining protocol7. The same study7 identifies alveolar mac-
rophages as the predominant iron positive cell population. Despite clear evidence of iron accumulation in lung 
tissue obtained from COPD patients, the source of iron remains obscure. Increased iron content in COPD lungs 
could possibly result from cigarette smoke exposure2,4, genetic predisposition e.g. IREB2 polymorphism2,3, alve-
olar microhemorrhage47, systemic inflammation47, air pollutants or other unknown factors. Iron laden alveolar 
macrophages have also been reported in Idiopathic Pulmonary Fibrosis47 and elevated iron levels have been found 
in the respiratory tracts of cystic fibrosis patients48. In addition to respiratory diseases, dysregulated iron metab-
olism and iron accumulation have been observed in neurodegenerative disease conditions such as Alzheimer’s 
disease, Parkinson’s disease, Multiple sclerosis and Amyotropic Lateral Sclerosis49,50.
Our study also has limitations. ToF-SIMS does not discriminate between oxidized, ferric (Fe3+) iron and sol-
uble ferrous (Fe2+) iron. At physiological pH, iron pre-dominantly exists as insoluble ferric iron, bound to carrier 
proteins such as transferrin51, ferritin9, lactoferrin52, ceruloplasmin53 and/or lipocalin 28, or unbound in the form 
of cell free hemoglobin/heme or non-transferrin bound iron (citrate or acetate bound iron), all of which are 
found in the BALF. To be absorbed, iron must be in the ferrous (Fe2+) state. Intracellular Fe2+ is then either stored 
Figure 2. Heterogeneous iron distribution has been shown in iron positive cells of COPD (GOLD IV) patients’ 
lung tissue. Top panel shows representative (a) total ion image, (b) the iron ion signal image, and (c) the overlay 
of the two images obtained from COPD (GOLD IV) patients’ lung tissue using delayed extraction mode in ToF-
SIMS instrument. Bottom panel shows a region of image (a) further magnified and their corresponding (d) total 
ion image, (e) iron ion signal image and (f) the overlay of both. Figure 2g shows a consecutive section of Perls’ 
Prussian blue/ nuclear fast red stained COPD (GOLD IV) patient lung tissue including alveolar macrophages 
(tentatively identified). Scale bar for figure (a–c) 50µm and figure (d–g) 20µm.
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(ferritin, mitochondrial ferritin, lysosome etc.) or utilized for essential biologic processes including heme synthe-
sis and Fe-S cluster synthesis. Under conditions of excessive intracellular iron, surplus iron may be deposited as 
insoluble polymeric iron(III) with oxo-bridges termed hemosiderin54. In this study we are unable to determine if 
the iron detected by ToF-SIMS is ferric, ferrous, insoluble or soluble or if it is bound to a specific protein. Further 
studies are required to determine the nature of this accumulated iron in COPD.
Iron is an essential trace element required for various biological processes, but when overabundant it may 
become pathogenic due to generation of free radicals, oxidative stress, and facilitation of bacterial infections18,48. 
Mitochondria are major cellular organelles that play a key role in iron metabolism, and they harbor major 
Figure 5. OPLS-DA analysis of positive mode data from the ToF-SIMS analysis of 3 human lung samples per 
group (healthy donor and COPD (GOLD IV)) with n = 3 replicates per sample. (a) Score plot of the ToF-SIMS 
data showing distinctive separation between healthy donors’ (Green dots) and COPD (GOLD IV) (Blue dots) 
samples. This model explains 85% of the variation in the data set (R2X cumulative) with predictive power of 
0.83% (Q2 cumulative). (b) Corresponding loading plot representing the m/z peaks with strong impact on the 
separation between the two groups.
Figure 4. PCA analysis of positive mode data from ToF-SIMS analysis of 3 human lung samples per group 
(healthy donor and COPD (GOLD IV)) with n = 3 replicates per sample. Score plot of the first principle 
component (t[1]) vs. the third principle component (t[3]) from the spectra. Green and blue dots represent 
healthy donors and COPD (GOLD IV) samples respectively.
Figure 3. Depth profiling of iron positive cells in COPD (GOLD IV) patients’ lung tissue. Red line indicates the 
iron signal, whereas the blue and gray lines depict phosphatidyl choline (PC) and cholesterol respectively.
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pathways for iron utilization and production of iron containing protein such as iron- sulphur cluster biosynthesis 
and heme synthesis55. Recently, it was demonstrated that mitochondrial iron loading holds a pivotal role in the 
development of bronchitis and emphysema, and that chelation of mitochondrial iron may alleviate cigarette smoke 
induced impairment of mucociliary clearance, pulmonary inflammation and lung injury in mice with experimen-
tal COPD1. Whether the heterogeneous iron distribution pattern observed in this study is due to iron accumula-
tion in selective cellular organelles such as mitochondria or lysosomes needs to be determined in future studies.
Conclusion
In this study, we demonstrate for the first time that ToF-SIMS can be successfully employed to image iron in 
human lung tissue sections, and that using delayed extraction mode enables imaging of the iron distribution 
pattern at cellular levels. Further, we show that relative quantification of lung tissue iron content is feasible with 
ToF-SIMS and that twelve times higher iron levels are present in lung tissue sections from COPD (GOLD IV) 
patients as compared to healthy donors. Most of this iron was shown to be heterogeneously distributed within the 
iron-positive cells, consistent with accumulation within discrete cellular organelles such as mitochondria or lys-
osomes. Using multivariate analysis OPLS-DA, we show that COPD patients and healthy controls can be clearly 
separated on basis of the chemical composition of their lung tissue. The iron signal was found to be a major driver 
causing this separation. However, other species, e.g. lipids, may contribute to the observed separation, which 
needs to be investigated in future studies.
Methods
Healthy Donors and CopD (GoLD IV) patients’ information. Transplanted lung tissue from three 
end stage COPD (GOLD IV) patients and three healthy donors age-matched to the COPD group were employed 
for this study. The studies were approved by the Swedish Research Ethical Committee (Gothenburg FEK 675-
12/2012, Lund FEK 91/2006). All research was performed in accordance with relevant guidelines and regulations. 
Signed informed consent forms were received from the study subjects or their closest relatives.
Human lung tissue sample preparation. The lung tissue was dissected into small pieces and fixed with 
4% buffered formalin over-night, followed by dehydration and paraffin embedding process as routinely per-
formed for biobank storage and described previously*56,57. 3 µm thick tissue sections were mounted on micro-
scopic glass slides and used for ToF-SIMS imaging and Perls’ Prussian blue iron staining.
toF-sIMs Imaging and data analysis. A ToF-SIMS 5 instrument (IONTOF GmbH, Germany) equipped 
with a liquid metal primary ion source was used for all ToF-SIMS experiments. Bi3++ primary ions at 25 keV 
energy were applied to record ToF-SIMS spectra of positive ions. Both the high current bunched mode with a 
mass resolution of m/∆m = 6000 fwhm at m/z 100, as well as the delayed extraction mode, with a mass resolution 
of m/∆m = 4000 fwhm at m/z 100 were used. The delayed extraction was set to an extraction voltage of 2 kV, 
the rise time to 40 ns and the delay was adjusted to 5 µs. The pulsed primary ion current was 0.3 pA and 0.25 pA 
for high current bunched mode and delayed extraction mode respectively. The maximum ion dose density of 
Bi3++ was kept below 4 × 1011 cm−2. To avoid charging effects, electron flooding was used. In total three sections 
obtained from three different donors in each group (healthy donor and COPD) with five random areas from each 
section were analyzed. Depth profile analysis was performed using pulsed Bi3++ gun (0.26 pA) while sputtering 
was carried out with a C60++ beam with a current of 0.78 nA.
The Surface Lab software (version 6.3 ION-ToF, GmbH, Germany) was used to analyze all ToF-SIMS data. 
For mass calibration, signals of [C]+, [CH]+, [CH2]+, [CH3]+, and [C5H15PNO4]+ were used. Spectra obtained 
from individual samples were analyzed using the search peaks function in the Surface Lab software. Parameters 
employed to select peaks were as followed: counts >100, S/N > 3, width 0.8 Da. In the following step, the com-
plete data set consisting of 804 peaks were normalized to the primary ion dose of the respective spectra and 
then subjected to principle component analysis (PCA) and orthogonal partial least squares discriminant analysis 
(OPLS-DA) data analysis using SIMCA (version 13.0, Umetrics, Umea, Sweden). Low mass peaks, m/z below 
30, were excluded from the analysis as they were related to redundant and not chemically specific peaks such as 
hydrocarbon clusters. The scores and loading plots revealed which ions (m/z values) were responsible for most of 
the variation between the two groups, healthy and COPD.
Hematoxylin and eosin (H&e) staining. Formalin-fixed, paraffin embedded lung tissue sections were 
deparaffinized and rehydrated using xylene and decreasing concentrations of alcohols and washed in de-ionized 
water. Tissue sections were then stained with Hematoxylin (HistoLab, Sweden) for 8 minutes and kept under 
running tap water for 5 minutes to allow stain to develop. The sections were then stained with eosin (Histolab, 
Sweden) for 5 minutes, after which they were dehydrated through treatment with increasing concentrations of 
alcohols and xylene. Finally, the tissue sections were mounted and scanned using Aperio CS2 scanner (Leica 
Biosystems, Germany), and analyzed using Aperio ImageScope (Leica Biosystems, Germany).
Perls’ Prussian blue/Iron staining. Formalin-fixed, paraffin embedded lung tissue sections were dep-
araffinized and rehydrated using xylene and decreasing concentrations of alcohols and washed in de-ionized 
water. Slides were then incubated in Perls’ stain (Iron assay kit, Sigma-Aldrich, Sweden) as per the manufacturer’s 
protocol for 30 minutes at room temperature (RT) and then washed with distilled water. For nuclear staining, 
slides were incubated with nuclear fast-red solution and incubated for 5 minutes at RT. Following, the slides were 
washed with distilled water for 5 minutes, dehydrated and mounted. Slides were scanned using Aperio CS2 scan-
ner (Leica Biosystems, Germany) and analyzed using Aperio ImageScope (Leica Biosystems, Germany).
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